But in one study, the comparison of DCIS (Ductal Carcinoma In Situ), invasive ductal carcinoma and metastatic lesions showed an increasing trend in ERα methylation with malignant progression (25). This evidence concerns the gene ESR1 and breast ductal adenocarcinoma.